These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35699810)

  • 1. Treatment of Oligometastatic Esophagogastric Cancer: A Spark of Light at the End of the Tunnel.
    Goense L
    Ann Surg Oncol; 2022 Aug; 29(8):4673-4675. PubMed ID: 35699810
    [No Abstract]   [Full Text] [Related]  

  • 2. Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer.
    Kroese TE; van Rossum PSN; Nilsson M; Lordick F; Smyth EC; Rosati R; Nafteux P; D'Ugo D; Chaudry MA; Polkowkski W; Roviello F; Gockel I; Kolodziejczyk P; Haustermans K; Guckenberger M; Nordsmark M; Hawkins MA; Cervantes A; Fleitas T; van Cutsem E; Moehler M; Wagner AD; van Laarhoven HWM; van Hillegersberg R;
    Eur J Surg Oncol; 2023 Jan; 49(1):21-28. PubMed ID: 36184420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASO Author Reflections: Role of Local Treatment for Oligometastatic Esophagogastric Cancer.
    Kroese TE; van Rossum PSN; van Hillegersberg R
    Ann Surg Oncol; 2022 Aug; 29(8):4858-4860. PubMed ID: 35307806
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis and treatment of esophagogastric junction cancer].
    Seto Y; Yamashita H
    Nihon Shokakibyo Gakkai Zasshi; 2015 Oct; 112(10):1769-75. PubMed ID: 26440679
    [No Abstract]   [Full Text] [Related]  

  • 5. [II. Treatment Strategy for Esophagogastric Junction Tumor].
    Hashimoto T; Kurokawa Y; Miyazaki Y; Takahashi T; Tanaka K; Makino T; Yamazaki M; Nakajima K; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2018 Sep; 45(9):1248-1253. PubMed ID: 30237365
    [No Abstract]   [Full Text] [Related]  

  • 6. The Management of Esophagogastric Cancers Enters a New Era.
    Shah MA
    Hematol Oncol Clin North Am; 2017 Jun; 31(3):xiii-xiv. PubMed ID: 28501094
    [No Abstract]   [Full Text] [Related]  

  • 7. [Multidisciplinary therapy for esophagogastric junction cancer].
    Sudo K; Honma Y; Kato K
    Nihon Shokakibyo Gakkai Zasshi; 2015 Oct; 112(10):1791-9. PubMed ID: 26440682
    [No Abstract]   [Full Text] [Related]  

  • 8. The Current Status of Immunotherapies in Esophagogastric Cancer.
    Ku GY
    Surg Oncol Clin N Am; 2017 Apr; 26(2):277-292. PubMed ID: 28279469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Oligometastatic Disease in Esophagogastric Cancer: What Is the Evidence?
    Hingorani M; Stubley H
    Oncol Res Treat; 2023; 46(7-8):312-319. PubMed ID: 37331340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].
    Moehler M; Al-Batran SE; Andus T; Anthuber M; Arends J; Arnold D; Aust D; Baier P; Baretton G; Bernhardt J; Boeing H; Böhle E; Bokemeyer C; Bornschein J; Budach W; Burmester E; Caca K; Diemer WA; Dietrich CF; Ebert M; Eickhoff A; Ell C; Fahlke J; Feussner H; Fietkau R; Fischbach W; Fleig W; Flentje M; Gabbert HE; Galle PR; Geissler M; Gockel I; Graeven U; Grenacher L; Gross S; Hartmann JT; Heike M; Heinemann V; Herbst B; Herrmann T; Höcht S; Hofheinz RD; Höfler H; Höhler T; Hölscher AH; Horneber M; Hübner J; Izbicki JR; Jakobs R; Jenssen C; Kanzler S; Keller M; Kiesslich R; Klautke G; Körber J; Krause BJ; Kuhn C; Kullmann F; Lang H; Link H; Lordick F; Ludwig K; Lutz M; Mahlberg R; Malfertheiner P; Merkel S; Messmann H; Meyer HJ; Mönig S; Piso P; Pistorius S; Porschen R; Rabenstein T; Reichardt P; Ridwelski K; Röcken C; Roetzer I; Rohr P; Schepp W; Schlag PM; Schmid RM; Schmidberger H; Schmiegel WH; Schmoll HJ; Schuch G; Schuhmacher C; Schütte K; Schwenk W; Selgrad M; Sendler A; Seraphin J; Seufferlein T; Stahl M; Stein H; Stoll C; Stuschke M; Tannapfel A; Tholen R; Thuss-Patience P; Treml K; Vanhoefer U; Vieth M; Vogelsang H; Wagner D; Wedding U; Weimann A; Wilke H; Wittekind C; ;
    Z Gastroenterol; 2011 Apr; 49(4):461-531. PubMed ID: 21476183
    [No Abstract]   [Full Text] [Related]  

  • 11. Esophageal and esophagogastric junction cancers, version 1.2015.
    Ajani JA; D'Amico TA; Almhanna K; Bentrem DJ; Besh S; Chao J; Das P; Denlinger C; Fanta P; Fuchs CS; Gerdes H; Glasgow RE; Hayman JA; Hochwald S; Hofstetter WL; Ilson DH; Jaroszewski D; Jasperson K; Keswani RN; Kleinberg LR; Korn WM; Leong S; Lockhart AC; Mulcahy MF; Orringer MB; Posey JA; Poultsides GA; Sasson AR; Scott WJ; Strong VE; Varghese TK; Washington MK; Willett CG; Wright CD; Zelman D; McMillian N; Sundar H;
    J Natl Compr Canc Netw; 2015 Feb; 13(2):194-227. PubMed ID: 25691612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis.
    Kroese TE; van Laarhoven HWM; Nilsson M; Lordick F; Guckenberger M; Ruurda JP; D'Ugo D; Haustermans K; van Cutsem E; van Hillegersberg R; van Rossum PSN
    Eur J Cancer; 2022 May; 166():254-269. PubMed ID: 35339868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophagogastric junction and gastric adenocarcinoma: current challenges and future directions.
    Saba NF
    Oncology (Williston Park); 2014 Jun; 28(6):520-1. PubMed ID: 25134327
    [No Abstract]   [Full Text] [Related]  

  • 14. What's New in Gastric and Esophageal Cancers.
    Tanabe K
    Ann Surg Oncol; 2016 Nov; 23(12):3773. PubMed ID: 27638669
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pretherapeutic misclassification of esophageal cancer and adenocarcinoma of the esophagogastric junction : Possibilities and clinical consequences].
    Gockel I; Lordick F; Lyros O; Kreuser N; Hölscher AH; Wittekind C
    Chirurg; 2020 Jan; 91(1):41-50. PubMed ID: 31372677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EURECCA oesophago-gastric cancer project.
    Allum W; Osorio J
    Cir Esp; 2016 May; 94(5):255-6. PubMed ID: 26944535
    [No Abstract]   [Full Text] [Related]  

  • 17. Three decades of oesophagogastric cancer care: now a curable disease.
    Phillips AW; Griffin SM
    Br J Surg; 2021 Jun; 108(6):595-597. PubMed ID: 33748863
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal management of esophageal adenocarcinoma: should we be CROSS?
    Smyth EC; Waddell TS; Cunningham D
    J Clin Oncol; 2014 Sep; 32(27):3080-1. PubMed ID: 25071100
    [No Abstract]   [Full Text] [Related]  

  • 19. Esophagogastric junction carcinoma: introduction.
    Goodman KA
    Semin Radiat Oncol; 2013 Jan; 23(1):1-2. PubMed ID: 23207040
    [No Abstract]   [Full Text] [Related]  

  • 20. Early diagnosis and management of esophageal and gastric cancer.
    Lang GD; Konda VJ
    Minerva Gastroenterol Dietol; 2013 Dec; 59(4):357-76. PubMed ID: 24212354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.